Intrinsic Value of S&P & Nasdaq Contact Us

Pasithea Therapeutics Corp. KTTA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
60/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
+315.5%

Pasithea Therapeutics Corp. (KTTA) has 17 known insider and institutional holders on record. The largest holder is PD Joint Holdings, LLC Series 2016-A with 2,608,696 shares. Other notable holders include Camac Partners, LLC and Shahinian Eric.

Over the last 12 months, insiders have made 12 transactions in KTTA stock — 11 buys (valued at $1.04M) and 1 sells (valued at $792.00). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

KTTA Insider Ownership

Top Holder
PD Joint Holdings, LLC Series 2016-A
2,608,696 shares
Buys (12 mo)
11
$1.04M value
Sells (12 mo)
1
$792.00 value
12-Month Transaction Activity
Buy 92%
Sell 8%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Pd Joint Holdings, Llc Series 2016-a 10 Percent Owner 2,608,696 2023-02-14
100%
2 Camac Partners, Llc Director 1,788,415 2022-09-30
69%
3 Shahinian Eric Other: Member of 10% Owner Group 1,781,705 2022-09-30
68%
4 Abramowitz Israel Maxx Officer 1,051,575 2021-10-07
40%
5 Geller Avi 10 Percent Owner 1,034,702 2022-08-15
40%
6 Lazer Eric Officer 902,600 2021-10-07
35%
7 Lazer Dean Officer 902,600 2021-10-07
35%
8 Bendiabdallah Yassine Chief Operating Officer 300,000 2021-09-14
11%
9 Delaney David Director 227,521 2022-10-19
9%
10 Steinman Lawrence Director 199,691 2025-12-01
8%
11 Marques Tiago Chief Executive Officer 73,334 2025-12-01
3%
12 Leonite Capital Llc Director 54,644 2022-08-26
2%
13 Novak Alfred J Director 42,913 2025-10-27
2%
14 Dumesnil Simon Director 35,833 2025-12-01
1%
15 Leahy Emer Director 33,333 2025-12-01
1%
16 Schneiderman Daniel H Chief Financial Officer 26,667 2025-12-01
1%
17 Currie Graeme Martin Chief Development Officer 5,938 2024-04-05
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2025-11-28 Dumesnil Simon Director Informative Buy 33,333 $0.75 $25K
2025-11-28 Marques Tiago Chief Executive Officer Informative Buy 33,333 $0.75 $25K
2025-11-28 Leahy Emer Director RSU Award 33,333 $0.75 $25K
2025-11-28 Schneiderman Daniel H Chief Financial Officer RSU Award 26,667 $0.75 $20K
2025-11-28 Steinman Lawrence Director Informative Buy 133,333 $0.75 $100K
2025-10-24 Dumesnil Simon Director RSU Award 42,913 $0.72 $30.68K
2025-10-24 Marques Tiago Chief Executive Officer RSU Award 493,341 $0.72 $352.74K
2025-10-24 Leahy Emer Director RSU Award 42,913 $0.72 $30.68K
2025-10-24 Schneiderman Daniel H Chief Financial Officer RSU Award 317,266 $0.72 $226.85K
2025-10-24 Novak Alfred J Director RSU Award 42,913 $0.72 $30.68K
2025-10-24 Steinman Lawrence Director RSU Award 242,913 $0.72 $173.68K
2025-05-12 Marques Tiago Chief Executive Officer Informative Sell 960 $0.83 $792.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message